refractory langerhans cell histiocytosis
Showing 1 - 12 of 12
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Trial in United States (Biospecimen
Recruiting
- Recurrent Langerhans Cell Histiocytosis
- Refractory Langerhans Cell Histiocytosis
- Biospecimen Collection
- +8 more
-
Wilmington, Delaware
- +3 more
Apr 28, 2023
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023
Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States
Recruiting
- Malignant Solid Neoplasm
- +40 more
- Biospecimen Collection
- +6 more
-
Birmingham, Alabama
- +172 more
Jan 27, 2023
Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +118 more
Jan 27, 2023
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis Trial (Biopsy, Biospecimen Collection,
Not yet recruiting
- Recurrent Langerhans Cell Histiocytosis
- Refractory Langerhans Cell Histiocytosis
- Biopsy
- +3 more
- (no location specified)
Dec 22, 2022
Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
- Pharmacokinetic Study
- Ulixertinib
-
Birmingham, Alabama
- +108 more
Oct 19, 2022
Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +37 more
-
Birmingham, Alabama
- +171 more
Aug 24, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +32 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +124 more
Aug 24, 2022
Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto
Recruiting
- Malignant Solid Neoplasm
- +26 more
- Ensartinib
- +2 more
-
Birmingham, Alabama
- +121 more
Aug 24, 2022
Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +30 more
- Larotrectinib Sulfate
-
Birmingham, Alabama
- +123 more
Aug 23, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
-
Birmingham, Alabama
- +113 more
Jun 28, 2022